Comment: Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine [3] (multiple letters)

Mong Liang Lu, Winston W. Shen, Igor Schillevoort, Anthonius De Boer, R. A C Roos, P. A F Jansen, H. G M Leufkens

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1292-1293
Number of pages2
JournalAnnals of Pharmacotherapy
Volume36
Issue number7-8
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Lu, M. L., Shen, W. W., Schillevoort, I., De Boer, A., Roos, R. A. C., Jansen, P. A. F., & Leufkens, H. G. M. (2002). Comment: Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine [3] (multiple letters). Annals of Pharmacotherapy, 36(7-8), 1292-1293.